Concurrent Use of Conventional Drugs with Chinese Herbal Products in Taiwan: A Population-based Study

Ming-Chen Chen, Jung-Nien Lai, Pau-Chung Chen, Jung-Der Wang, Ming-Chen Chen, Jung-Nien Lai, Pau-Chung Chen, Jung-Der Wang

Abstract

The increased use of Chinese herbal products (CHPs) worldwide has raised the concern of herb-drug interactions. The aim of this study was to determine the prevalence and utilization patterns of concurrent use of conventional drugs and CHPs in Taiwan. The usage and frequency of services in the co-prescription of a CHP and a conventional drug were evaluated. Subjects were recruited from a simple random sample of 1,000,000 subjects from over 22 million beneficiaries of the National Health Insurance in 2007. The logistic regression method was employed to estimate the odds ratios (ORs) for the co-prescription of a CHP and a conventional drug (CH + D) and a conventional drug alone (D-alone). The prevalence of the CH + D was 14.1%. Females, regular salary earners, and elderly (65 years and above) were more likely to consume a CHP and a conventional drug concurrently. Painkillers, especially acetaminophen, and anti-cough medicines were the top two conventional drugs that were most frequently co-prescribed with a CHP. Anti-cough medication is the most common conventional drug co-prescribed with CHP, after painkillers. We recommend that safety issues be investigated in future research and integrating both healthcare technologies may be beneficial for the overall health and quality of life of patients.

Keywords: Chinese herbal product; Co-prescription; Conventional drug; Herb–drug interaction.

Figures

Figure 1
Figure 1
Prevalence of co-prescriptions of Chinese herbal products and conventional drugs among the cohort of users of conventional medicine at the outpatient departments, 1997-2007

References

    1. World Health Organization. The regional strategy for traditional medicine in the Western Pacific. (2011-2020) [Last accessed on 2013 Oct 02]. Available from:
    1. Eisenberg DM, Kessler RC, Van Rompay MI, Kaptchuk TJ, Wilkey SA, Appel S, et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both: Results from a national survey. Ann Intern Med. 2001;135:344–51.
    1. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA. 1998;280:1569–75.
    1. Casey M, Adams J, Sibbritt D. An examination of the clinical practices and perceptions of professional herbalists providing patient care concurrently with conventional medical practice in Australia. Complement Ther Med. 2008;16:228–32.
    1. Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355:134–8.
    1. Miller LG. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998;158:2200–11.
    1. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: An updated systematic review. Drugs. 2009;69:1777–98.
    1. Zhou S, Huang M, Xu A, Yang H, Duan W, Paxton JW. Prediction of herb–drug metabolic interactions: A simulation study. Phytother Res. 2005;19:464–71.
    1. Li CG, Yang L, Zhou S-F. Interaction between Chinese herbal medicines and drugs. Aust J Acupunct Chin Med. 2007;2:17–24.
    1. Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, et al. Herb-drug interactions: A literature review. Drugs. 2005;65:1239–82.
    1. Forrest J, Clements JA, Prescott LF. Clinical Pharmacokinetics of Paracetamol-Springer. Clinical Pharmacokinet. 1982;7:93–107.
    1. Verbeeck RK, Blackburn JL, Loewen GR. Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet. 1983;8:297–331.
    1. Zhou L, Zuo Z, Chow MS. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol. 2005;45:1345–59.
    1. Bush TM, Rayburn KS, Holloway SW, Sanchez-Yamamoto DS, Allen BL, Lam T, et al. Adverse interactions between herbal and dietary substances and prescription medications: A clinical survey. Altern Ther Health Med. 2007;13:30–5.
    1. Ng TP, Tan CH, Kua EH. Singapore Chinese Longitudinal Aging Study. The use of Chinese herbal medicines and their correlates in Chinese older adults: The Singapore Chinese Longitudinal Aging Study. Age Ageing. 2004;33:135–42.
    1. Loh CH. Use of traditional Chinese medicine in Singapore children: Perceptions of parents and paediatricians. Singapore Med J. 2009;50:1162–8.
    1. Lee YC, Huang YT, Tsai YW, Huang SM, Kuo KN, McKee M, et al. The impact of universal National Health Insurance on population health: The experience of Taiwan. BMC Health Serv Res. 2010;10:225.
    1. Chen FP, Chen TJ, Kung YY, Chen YC, Chou LF, Chen FJ, et al. Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res. 2007;7:26.
    1. Chang LC, Huang N, Chou YJ, Lee CH, Kao FY, Huang YT. Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003. BMC Health Serv Res. 2008;8:170.
    1. Hsieh SC, Lai JN, Lee CF, Hu FC, Tseng WL, Wang JD. The prescribing of Chinese herbal products in Taiwan: A cross-sectional analysis of the national health insurance reimbursement database. Pharmacoepidemiol Drug Saf. 2008;17:609–19.
    1. National Health Research Institutes. National Health Insurance Research database. [Last accessed on 2013 Oct 02]. Available from: .
    1. Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision (ICD-9) 1979. [Last cited in 2009 Oct 21]. Available from: .
    1. Department of Chinese Medicine and Pharmacy (previous name: Committee on Chinese Medicine and Pharmacy), Ministry of Health and Welfare, Taiwan. [Last accessed on 2013 Oct 02]. .
    1. Chen LC, Wang BR, Chou YC, Tien JH. Drug utilization pattern of Chinese herbal medicines in a general hospital in Taiwan. Pharmacoepidemiol Drug Saf. 2005;14:651–7.
    1. Lim M, Sadarangani P, Chan H, Heng J. Complementary and alternative medicine use in multiracial Singapore. Compl Therap Med. 2005;13:16–24.
    1. Cassidy CM. Chinese medicine users in the United States part I: Utilization, satisfaction, medical plurality. J Altern Complement Med. 1998;4:17–27.
    1. Kang J, Lee C, Chen C. Factors related to the choice of clinic between Chinese traditional medicine and Western medicine. J Formos Med Assoc. 1994;93:S49–55.
    1. Chi C, Lee J, Lai J, Chen S. Utilization of Chinese medicine in Taiwan. Altern Ther Health Med. 1997;3:40–53.
    1. Chou P. Factors related to utilization of traditional Chinese medicine in Taiwan. Zhonghua Yi Xue Za Zhi (Taipei) 2001;64:191–202.
    1. Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS. Insurance coverage, medical conditions, and visits to alternative medicine providers: Results of a National survey. Archives of Internal Medicine. JAMA. 2002;162:281–7.
    1. Ma GX. Between two worlds: The use of traditional and Western health services by Chinese immigrants. J Commun Health. 1999;24:421–37.
    1. Druss B. Association between use of unconventional therapies and conventional medical services. JAMA. 1999;287:651–6.
    1. Cleary-Guida MB, Okvat HA, Oz MC, Ting W. A regional survey of health insurance coverage for complementary and alternative medicine: Current status and future ramifications. J Altern Complement Med. 2001;7:269–73.
    1. Ma H, Lum C, Dai L. Potentially inappropriate medication in elderly patients in outpatient clinics. Asian J Gerontol Geriatr. 2008;3:27–33.
    1. Lin HY, Liao CC, Cheng SH, Wang PC, Hsueh YS. Association of potentially inappropriate medication use with adverse outcomes in ambulatory elderly patients with chronic diseases. Drugs Aging. 2008;25:49–59.
    1. Chen YC, Hwang SJ, Lai HY, Chen TJ, Lin MH, Chen LK, et al. Potentially inappropriate medication for emergency department visits by elderly patients in Taiwan. Pharmacoepidemiol Drug Saf. 2009;18:53–61.
    1. Williams CM. Using medications appropriately in older adults. Am Fam Physician. 2002;66:1917–25.
    1. Dergal JM, Gold JL, Laxer DA, Lee MS, Binns MA, Lanctôt KL, et al. Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging. 2002;19:879–86.
    1. Roy MJ, Koslowe PA, Kroenke K, Magruder C. Signs, symptoms, and ill-defined conditions in Persian Gulf War veterans: Findings from the Comprehensive Clinical Evaluation Program. Psychosom Med. 1998;60:663–8.
    1. Yeh LL, Liu JY, Liu YS, Lin KS, Tsai TF, Wang LH. Anemia-related hemogram, uterine artery pulsatility index, and blood pressure for the effects of Four-Agents-Decoction (Si Wu Tang) in the treatment of primary dysmenorrhea. J Altern Complement Med. 2009;15:531–8.
    1. Yeh LL, Liu JY, Lin KS, Liu YS, Chiou JM, Liang KY, et al. A randomised placebo-controlled trial of a traditional Chinese herbal formula in the treatment of primary dysmenorrhoea. PLoS One. 2007;2:e719.
    1. Delgoda R, Younger N, Barrett C, Braithwaite J, Davis D. The prevalence of herbs use in conjunction with conventional medicines in Jamaica. Complement Ther Med. 2010;18:13–20.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit